Skip to main content

Articles

Page 132 of 145

  1. Integrins are heterodimeric receptors that play a critical role in cell-cell and cell-matrix adhesion processes. Among them, αVβ3 integrin, that recognizes the aminoacidic RGD triad, is reported to be involved in...

    Authors: Gaetano Santulli, Maria Felicia Basilicata, Mariarosaria De Simone, Carmine Del Giudice, Antonio Anastasio, Daniela Sorriento, Michele Saviano, Annarita Del Gatto, Bruno Trimarco, Carlo Pedone, Laura Zaccaro and Guido Iaccarino
    Citation: Journal of Translational Medicine 2011 9:7
  2. In recent years, microRNAs (miRNAs) have been found to play an essential role in tumor development. In lung tumorigenesis, targets and pathways of miRNAs are being revealed, and further translational research ...

    Authors: Tom Donnem, Katrine Eklo, Thomas Berg, Sveinung W Sorbye, Kenneth Lonvik, Samer Al-Saad, Khalid Al-Shibli, Sigve Andersen, Helge Stenvold, Roy M Bremnes and Lill-Tove Busund
    Citation: Journal of Translational Medicine 2011 9:6
  3. It has been suggested that p300 participates in the regulation of a wide range of cell biological processes and mutation of p300 has been identified in certain types of human cancers. However, the expression d...

    Authors: Mei Li, Rong-Zhen Luo, Jie-Wei Chen, Yun Cao, Jia-Bin Lu, Jie-Hua He, Qiu-Liang Wu and Mu-Yan Cai
    Citation: Journal of Translational Medicine 2011 9:5
  4. Aminoglycoside ototoxicity is one of the common health problems. Mitochondrial 12S rRNA mutations are one of the important causes of aminoglycoside ototoxicity. However, the incidences of 12S rRNA mutations as...

    Authors: Zhisen Shen, Jing Zheng, Bobei Chen, Guanghua Peng, Ting Zhang, Shasha Gong, Yi Zhu, Chuqin Zhang, Ronghua Li, Li Yang, Jianjin Zhou, Ting Cai, Lihua Jin, Jianxin Lu and Min-Xin Guan
    Citation: Journal of Translational Medicine 2011 9:4
  5. Lung cancers consist of four major types that and for clinical-pathological reasons are often divided into two broad categories: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). All major ...

    Authors: Tonia Buonomo, Laura Carraresi, Mara Rossini and Rosanna Martinelli
    Citation: Journal of Translational Medicine 2011 9:2
  6. Inflammatory breast cancer (IBC) is the most aggressive form of breast cancer. In non-IBC, the cysteine protease cathepsin B (CTSB) is known to be involved in cancer progression and invasion; however, very lit...

    Authors: Mohamed A Nouh, Mona M Mohamed, Mohamed El-Shinawi, Mohamed A Shaalan, Dora Cavallo-Medved, Hussein M Khaled and Bonnie F Sloane
    Citation: Journal of Translational Medicine 2011 9:1
  7. Precise criteria for optimal patient selection for adjuvant chemotherapy remain controversial and include subjective components such as tumour morphometry (pathological grade). There is a need to replace subje...

    Authors: Mauro Tambasco, Misha Eliasziw and Anthony M Magliocco
    Citation: Journal of Translational Medicine 2010 8:140
  8. Biliary atresia (BA) is a typical cholestatic neonatal disease, characterized by obliteration of intra- and/or extra-hepatic bile ducts. However, the mechanisms contributing to the pathogenesis of BA remain un...

    Authors: Ming-Huei Chou, Jiin-Haur Chuang, Hock-Liew Eng, Ching-Mei Chen, Chiou-Huey Wang, Chao-Long Chen and Tsun-Mei Lin
    Citation: Journal of Translational Medicine 2010 8:138
  9. Proteomic-based discovery of biomarkers for disease has recently come under scrutiny for a variety of issues; one prominent issue is the lack of orthogonal validation for biomarkers following discovery. Valida...

    Authors: Nicole Haverland, Gwënaël Pottiez, Jayme Wiederin and Pawel Ciborowski
    Citation: Journal of Translational Medicine 2010 8:137
  10. Adenoid cystic carcinoma is one of the most common types of salivary gland cancers. The poor long-term prognosis for patients with adenoid cystic carcinoma is mainly due to local recurrence and distant metasta...

    Authors: Qin Xu, Xiuming Liu, Wantao Chen and Zhiyuan Zhang
    Citation: Journal of Translational Medicine 2010 8:136
  11. Immunohistochemistry (IHC) with mutation-specific antibodies may be an ancillary method of detecting EGFR mutations in lung cancer patients.

    Authors: Sara Simonetti, Miguel Angel Molina, Cristina Queralt, Itziar de Aguirre, Clara Mayo, Jordi Bertran-Alamillo, José Javier Sanchez, Jose Luis Gonzalez-Larriba, Ulpiano Jimenez, Dolores Isla, Teresa Moran, Santiago Viteri, Carlos Camps, Rosario Garcia-Campelo, Bartomeu Massuti, Susana Benlloch…
    Citation: Journal of Translational Medicine 2010 8:135
  12. The human IGF2-P4 and H19 promoters are highly active in a variety of human cancers (including bladder cancer), while existing at a nearly undetectable level in the surrounding normal tissue.

    Authors: Doron Amit and Abraham Hochberg
    Citation: Journal of Translational Medicine 2010 8:134
  13. Apoptosis is an early event involved in cardiomyopathy associated with diabetes mellitus. Toll-like receptor (TLR) signaling triggers cell apoptosis through multiple mechanisms. Up-regulation of TLR4 expressio...

    Authors: Yuwei Zhang, Tianqing Peng, Huaqing Zhu, Xiufen Zheng, Xusheng Zhang, Nan Jiang, Xiaoshu Cheng, Xiaoyan Lai, Aminah Shunnar, Manpreet Singh, Neil Riordan, Vladimir Bogin, Nanwei Tong and Wei-Ping Min
    Citation: Journal of Translational Medicine 2010 8:133
  14. Developing new vaccination strategies and optimizing current vaccines through heterologous prime-boost carries the promise of integrating the benefits of different yet synergistic vectors. It has been widely t...

    Authors: Adrian Bot, Zhiyong Qiu, Raymond Wong, Mihail Obrocea and Kent A Smith
    Citation: Journal of Translational Medicine 2010 8:132
  15. The International Society for Biological Therapy of Cancer (iSBTc, recently renamed the Society for Immunotherapy of Cancer, SITC) hosted a one-day symposium at the National Institutes of Health on September 3...

    Authors: Lisa H Butterfield, Mary L Disis, Samir N Khleif, James M Balwit and Francesco M Marincola
    Citation: Journal of Translational Medicine 2010 8:130
  16. Cytokine-induced killer (CIK) cells are typically differentiated in vitro with interferon (IFN)-γ and αCD3 monoclonal antibodies (mAb), followed by the repeated provision of interleukin (IL)-2. It is presently un...

    Authors: Giuseppina Bonanno, Paola Iudicone, Andrea Mariotti, Annabella Procoli, Annino Pandolfi, Daniela Fioravanti, Maria Corallo, Alessandro Perillo, Giovanni Scambia, Luca Pierelli and Sergio Rutella
    Citation: Journal of Translational Medicine 2010 8:129
  17. Platelet activation requires rapid remodeling of the actin cytoskeleton which is regulated by small GTP-binding proteins. By using the Rac1-specific inhibitor NSC23766, we have recently found that Rac1 is a ce...

    Authors: Suman Dwivedi, Dharmendra Pandey, Anna L Khandoga, Richard Brandl and Wolfgang Siess
    Citation: Journal of Translational Medicine 2010 8:128
  18. Mutations in the GJB2 gene are the most common cause of nonsyndromic recessive hearing loss in China. In about 6% of Chinese patients with severe to profound sensorineural hearing impairment, only monoallelic GJB...

    Authors: Yongyi Yuan, Fei Yu, Guojian Wang, Shasha Huang, Ruili Yu, Xin Zhang, Deliang Huang, Dongyi Han and Pu Dai
    Citation: Journal of Translational Medicine 2010 8:127
  19. DNA polymerase η (pol η) is capable of bypassing DNA adducts produced by cisplatin or oxaliplatin and is associated with cellular tolerance to platinum. Previous studies showed that defective pol η resulted in...

    Authors: Kai-yuan Teng, Miao-zhen Qiu, Zhuang-hua Li, Hui-yan Luo, Zhao-lei Zeng, Rong-zhen Luo, Hui-zhong Zhang, Zhi-qiang Wang, Yu-hong Li and Rui-hua Xu
    Citation: Journal of Translational Medicine 2010 8:126
  20. Magnetic resonance imaging has been used in the diagnosis of human prion diseases such as sCJD and vCJD, but patients are scanned only when clinical signs appear, often at the late stage of disease. This study...

    Authors: Alexia L McKnight, Lawrence A Minkoff, Diane L Sutton, Bruce V Thomsen, Perry L Habecker, Raymond W Sweeney, Gary Smith, Constantin A Dasanu, Thomas E Ichim, Doru T Alexandrescu and Joel M Stutman
    Citation: Journal of Translational Medicine 2010 8:125
  21. Bortezomib, an NFkB inhibitor, is an active agent for the treatment of myeloma (MM). We have reported a promising complete remission (CR) rate for newly diagnosed myeloma patients treated by a staged approach,...

    Authors: Chor Sang Chim
    Citation: Journal of Translational Medicine 2010 8:124
  22. Authors: V Ruiz-Esquide, M J Gómara, V Peinado, J A Gómez-Puerta, M V Hernández, J A Barberá, J D Cañete, I Haro and R Sanmartí
    Citation: Journal of Translational Medicine 2010 8(Suppl 1):P55

    This article is part of a Supplement: Volume 8 Supplement 1

  23. Authors: R Cascão, R A Moura, I Perpétuo, H Canhão, E Vieira de Sousa, A F Mourão, A M Rodrigues, J Polido-Pereira, M Viana Queiroz, H S Rosário, M M Souto-Carneiro, L Graca and J E Fonseca
    Citation: Journal of Translational Medicine 2010 8(Suppl 1):P34

    This article is part of a Supplement: Volume 8 Supplement 1

Annual Journal Metrics